Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/38556
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorBURZYKOWSKI, Tomasz
dc.contributor.advisorCRASS, Ryan
dc.contributor.advisorBYON, Wonkyung
dc.contributor.authorNhim, Malai
dc.date.accessioned2022-09-26T08:21:18Z-
dc.date.available2022-09-26T08:21:18Z-
dc.date.issued2022
dc.identifier.urihttp://hdl.handle.net/1942/38556-
dc.format.mimetypeApplication/pdf
dc.languageen
dc.publishertUL
dc.titleEfficacy and Safety of Ibrutinib Alone or as Combination Treatment in Patients with non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis
dc.typeTheses and Dissertations
local.bibliographicCitation.jcatT2
dc.description.notesMaster of Statistics and Data Science-Biostatistics
local.type.specifiedMaster thesis
item.fullcitationNhim, Malai (2022) Efficacy and Safety of Ibrutinib Alone or as Combination Treatment in Patients with non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis.-
item.contributorNhim, Malai-
item.fulltextWith Fulltext-
item.accessRightsOpen Access-
Appears in Collections:Master theses
Files in This Item:
File Description SizeFormat 
db37e5ca-8672-4254-888d-1b7e424fc94a.pdf1.6 MBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.